Suppr超能文献

相似文献

1
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.
Science. 2010 Nov 5;330(6005):831-5. doi: 10.1126/science.1191175.
2
Cancer. Targeting bacteria to improve cancer therapy.
Science. 2010 Nov 5;330(6005):766-7. doi: 10.1126/science.1198310.
3
Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity.
Mol Pharmacol. 2013 Aug;84(2):208-17. doi: 10.1124/mol.113.085852. Epub 2013 May 20.
4
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.
Chem Biol. 2015 Sep 17;22(9):1238-49. doi: 10.1016/j.chembiol.2015.08.005. Epub 2015 Sep 10.
5
Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors.
J Biomol Screen. 2012 Aug;17(7):957-65. doi: 10.1177/1087057112444927. Epub 2012 Apr 24.
6
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
Cancer Chemother Pharmacol. 2006 Oct;58(4):494-503. doi: 10.1007/s00280-006-0187-8. Epub 2006 Jan 25.
8
Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
Int J Exp Pathol. 2009 Oct;90(5):489-99. doi: 10.1111/j.1365-2613.2009.00671.x.
10
Identify old drugs as selective bacterial β-GUS inhibitors by structural-based virtual screening and bio-evaluations.
Chem Biol Drug Des. 2020 Mar;95(3):368-379. doi: 10.1111/cbdd.13655. Epub 2020 Jan 2.

引用本文的文献

1
Clinical Detection and Management of Colorectal Cancer Concerning the Gut Microbiome.
Scientifica (Cairo). 2025 Sep 8;2025:1945321. doi: 10.1155/sci5/1945321. eCollection 2025.
4
Bioinformatic Methodologies in Assessing Gut Microbiota.
Microbiol Res (Pavia). 2024 Dec;15(4):2554-2574. doi: 10.3390/microbiolres15040170. Epub 2024 Dec 3.
5
The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review.
NPJ Precis Oncol. 2025 Jul 30;9(1):265. doi: 10.1038/s41698-025-01034-0.
6
Microbiota and kidney disease: the road ahead.
Nat Rev Nephrol. 2025 Oct;21(10):702-716. doi: 10.1038/s41581-025-00988-5. Epub 2025 Jul 28.
8
Deciphering allosterism of an hexuronate metabolism regulator: UxuR.
RSC Med Chem. 2025 Jun 30. doi: 10.1039/d5md00391a.
9
Safe and Efficient Intracellular Release of SN38 via Lysosomal-Responsive SN38-G Loaded Liposomes.
ACS Appl Bio Mater. 2025 Jul 21;8(7):6231-6242. doi: 10.1021/acsabm.5c00722. Epub 2025 Jul 8.
10
Ecological management of the microbiota in patients with cancer.
Nat Rev Clin Oncol. 2025 Jun 27. doi: 10.1038/s41571-025-01049-3.

本文引用的文献

1
Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.
Ther Adv Med Oncol. 2010 Jan;2(1):51-63. doi: 10.1177/1758834009355164.
3
Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
Cancer Chemother Pharmacol. 2010 Feb;65(3):503-8. doi: 10.1007/s00280-009-1056-z. Epub 2009 Jul 5.
4
CDD: specific functional annotation with the Conserved Domain Database.
Nucleic Acids Res. 2009 Jan;37(Database issue):D205-10. doi: 10.1093/nar/gkn845. Epub 2008 Nov 4.
6
The human microbiome project.
Nature. 2007 Oct 18;449(7164):804-10. doi: 10.1038/nature06244.
7
Bacteria, inflammation, and colon cancer.
World J Gastroenterol. 2006 Nov 14;12(42):6741-6. doi: 10.3748/wjg.v12.i42.6741.
9
Topoisomerase I inhibitors: camptothecins and beyond.
Nat Rev Cancer. 2006 Oct;6(10):789-802. doi: 10.1038/nrc1977.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验